Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis.
de Miguel
Rebeca
R
Hospital Complex Toledo, Spain.
el-Azhary
Rokea
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001691:Biological Therapy / Q000009:adverse effects / Q000191:economics; D002648:Child; D003033:Coal Tar / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D016208:Databases, Factual; D016527:Drug Costs; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000191:economics / Q000532:radiotherapy*; D012074:Remission Induction; D012189:Retrospective Studies; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy / Q000009:adverse effects / Q000191:economics; D055815:Young Adult
D007641:Keratolytic Agents; D003033:Coal Tar